topic
Good news about Biotech
Positive stories about Biotech, gathered from the newsrooms Rally reads. Every headline links back to the publisher who reported it.
7 stories.
What would it take to terraform Mars? Erika DeBenedictis has ideas
A biotech startup is developing microbes adapted to Mars, aiming to make the planet more habitable. This research could help future explorers survive and thrive in extreme environments. It’s a step toward unlocking the potential of other worlds for human life.
Scientific American
Oncolytics Biotech® Reports Accelerating Enrollment in Randomized REO 033 RAS-Mutant, MSS Colorectal Cancer Study
Oncolytics Biotech has activated nearly all clinical sites for its REO 033 study, enrolling multiple patients with a specific type of colorectal cancer. The company expects to share interim data by the end of 2026, potentially speeding up approval for a treatment that could help patients with limited options. This progress offers hope for faster access to new therapies.
Financial Post
Meet the under-35s shaping the future of biotech
MIT Technology Review has recognized 35 young innovators under 35 whose groundbreaking work in science and technology could shape the future of their fields. The list highlights the next generation of leaders driving progress in biotech and beyond. Their research offers hope for meaningful advancements in years to come.
MIT Technology Review
The Download: biotech’s future and cheaper, cleaner steel
MIT Technology Review spotlights young innovators driving progress in biotech, offering a glimpse into the field’s future. Meanwhile, breakthroughs in steel production promise cleaner, more affordable materials. These advances could reshape industries and reduce environmental impact.
MIT Technology Review
When AI designs a drug, who gets the credit?
AI is now helping design drugs, accelerating the discovery process. Insilico Medicine credited its AI platform for proposing a potential treatment for pulmonary fibrosis, marking a shift in how medical breakthroughs are achieved. This could speed up the development of new medicines, benefiting patients and researchers alike.
MIT Technology Review
Montana’s plan to become an experimental medical hub just pushed forward
Montana has created a new process for biotech companies to sell experimental drugs after minimal testing, offering hope for faster access to treatments. The state’s review board will assess applications, providing a clear path for innovation. This expansion of the “right to try” could help patients and researchers alike.
MIT Technology Review
Reed Jobs would rather talk about curing cancer than his last name
Reed Jobs is building a biotech venture firm with a growing team, focusing on drugs losing patent protection. He’s passionate about his work and downplays his famous last name, keeping the conversation on curing cancer. His approach could help bring affordable treatments to patients.
TechCrunch
